[Reversible posterior leukoencephalopathy syndrome associated to bevacizumab].

MLA

Ortiz-Lopez, Esther M., et al. “[Reversible Posterior Leukoencephalopathy Syndrome Associated to Bevacizumab].” Revista de Neurologia, vol. 51, no. 2, July 2010, pp. 117–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20602317&authtype=sso&custid=ns315887.

APA

Ortiz-Lopez, E. M., Gonzalez-Nieto, J. A., Rojas-Marcos, I., & Blanco-Ollero, A. (2010). [Reversible posterior leukoencephalopathy syndrome associated to bevacizumab]. Revista de Neurologia, 51(2), 117–118.

Chicago

Ortiz-Lopez, Esther M, José Antonio Gonzalez-Nieto, Iñigo Rojas-Marcos, and Alberto Blanco-Ollero. 2010. “[Reversible Posterior Leukoencephalopathy Syndrome Associated to Bevacizumab].” Revista de Neurologia 51 (2): 117–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20602317&authtype=sso&custid=ns315887.